Charles Schwab’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,086
Closed -$24K 3571
2021
Q1
$24K Buy
+1,086
New +$81.3K ﹤0.01% 3483
2019
Q2
Sell
-2,502
Closed -$109K 3280
2019
Q1
$109K Hold
2,502
﹤0.01% 3086
2018
Q4
$118K Hold
2,502
﹤0.01% 3081
2018
Q3
$379K Buy
2,502
+2,189
+699% +$957K ﹤0.01% 2931
2018
Q2
$449K Hold
313
﹤0.01% 2839
2018
Q1
$626K Buy
313
+45
+17% +$98.8K ﹤0.01% 2667
2017
Q4
$616K Sell
268
-29
-10% -$66.3K ﹤0.01% 2671
2017
Q3
$721K Hold
297
﹤0.01% 2612
2017
Q2
$556K Hold
297
﹤0.01% 2654
2017
Q1
$798K Buy
297
+144
+94% +$278K ﹤0.01% 2498
2016
Q4
$250K Buy
153
+50
+49% +$95.4K ﹤0.01% 2906
2016
Q3
$287K Hold
103
﹤0.01% 2806
2016
Q2
$172K Hold
103
﹤0.01% 2986
2016
Q1
$222K Hold
103
﹤0.01% 2868
2015
Q4
$346K Sell
103
-37
-26% -$132K ﹤0.01% 2807
2015
Q3
$509K Hold
140
﹤0.01% 2617
2015
Q2
$563K Hold
140
﹤0.01% 2631
2015
Q1
$563K Buy
140
+59
+73% +$288K ﹤0.01% 2587
2014
Q4
$390K Hold
81
﹤0.01% 2727
2014
Q3
$203K Hold
81
﹤0.01% 2945
2014
Q2
$257K Buy
+81
New +$267K ﹤0.01% 2923

Other funds holding ACGN

Charles Schwab's ACGN Position: Q2 2021 in Review

Charles Schwab sold out of Aceragen Inc (ACGN) in Q2 2021, closing a stake of 1,086 shares — an estimated $24K sold.

Charles Schwab first reported a position in ACGN in Q2 2014 and held it in 21 quarters. The position peaked at $798K in Q1 2017. 47 funds tracked by Wall St. Rank hold ACGN as of Q2 2021.

  • Charles Schwab reported no remaining Aceragen Inc position as of Q2 2021 after selling out during the quarter.
  • Charles Schwab sold 1,086 Aceragen Inc shares in Q2 2021, an estimated $24K.
  • Charles Schwab first reported a position in Aceragen Inc in Q2 2014 and held it in 21 quarters.
  • Charles Schwab's Aceragen Inc position peaked at $798K in Q1 2017.
  • 47 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2021.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.